152 related articles for article (PubMed ID: 34702619)
1. Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis.
Fan X; Li X; Wan K; Zhao X; Deng Y; Chen Z; Luan X; Lu S; Liu H
Vaccine; 2021 Nov; 39(47):6860-6865. PubMed ID: 34702619
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
Wu M; Li M; Yue Y; Xu W
Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
[TBL] [Abstract][Full Text] [Related]
3. Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Guérin.
Rao V; Dhar N; Tyagi AK
Scand J Immunol; 2003 Oct; 58(4):449-61. PubMed ID: 14507310
[TBL] [Abstract][Full Text] [Related]
4. A novel multi-component protein vaccine ECP001 containing a protein polypeptide antigen nPstS1 riching in T-cell epitopes showed good immunogenicity and protection in mice.
Yu J; Fan X; Luan X; Wang R; Cao B; Qian C; Li G; Li M; Zhao X; Liu H; Wan K; Yuan X
Front Immunol; 2023; 14():1138818. PubMed ID: 37153610
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of recombinant Mycobacterium bovis bacille Calmette-Guèrin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens.
Mohamud R; Azlan M; Yero D; Alvarez N; Sarmiento ME; Acosta A; Norazmi MN
BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S5. PubMed ID: 23458635
[TBL] [Abstract][Full Text] [Related]
6. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
7. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
10. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
[TBL] [Abstract][Full Text] [Related]
11. pstS1 polymorphisms of Mycobacterium tuberculosis strains may reflect ongoing immune evasion.
Liu H; Jiang Y; Dou X; Wang H; Zhao X; Zhang W; Wan L; Zhang Z; Chen C; Wan K
Tuberculosis (Edinb); 2013 Sep; 93(5):475-81. PubMed ID: 23849889
[TBL] [Abstract][Full Text] [Related]
12. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
15. A novel multistage antigens ERA005f confer protection against
Fan X; Zhao X; Wang R; Li M; Luan X; Wang R; Wan K; Liu H
Front Immunol; 2023; 14():1276887. PubMed ID: 38022539
[TBL] [Abstract][Full Text] [Related]
16. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
17. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
[TBL] [Abstract][Full Text] [Related]
18. Exploring the immunogenicity of Rv2201-519: A T-cell epitope-based antigen derived from Mycobacterium tuberculosis AsnB with implications for tuberculosis infection detection and vaccine development.
Luan X; Fan X; Li G; Li M; Li N; Yan Y; Zhao X; Liu H; Wan K
Int Immunopharmacol; 2024 Mar; 129():111542. PubMed ID: 38342063
[TBL] [Abstract][Full Text] [Related]
19. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.
Mustafa AS; Shaban FA; Abal AT; Al-Attiyah R; Wiker HG; Lundin KE; Oftung F; Huygen K
Infect Immun; 2000 Jul; 68(7):3933-40. PubMed ID: 10858206
[TBL] [Abstract][Full Text] [Related]
20. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX.
Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B
Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
